TKDA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Takeda Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 14.8 EUR -3.9% Market Closed

Market Cap: €46.4B

T	Takeda Pharmaceutical Co Ltd SWB:TKDA	JP
P	Pinnacle Financial Partners Inc F:PFZ	US
C	Ctac NV F:TAC	NL

Profitability Summary

Takeda Pharmaceutical Co Ltd's profitability score is 49/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

69% > 65%

Healthy Operating Margin

15%

Sustainable 3Y Average Operating Margin

11%

Operating Margin is Increasing

13% > 15%

Negative Net Margin

-3%

Low 3Y Average Net Margin

Declining Net Margin

7% > -3%

Exceptional Free Cash Flow Margin

14%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

View All

Hide

Collapse

49 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.